NuVasive Future Growth
Future criteria checks 3/6
NuVasive is forecast to grow earnings and revenue by 29.9% and 6% per annum respectively while EPS is expected to grow by 28.8% per annum.
Key information
29.9%
Earnings growth rate
28.8%
EPS growth rate
Medical Equipment earnings growth | 0% |
Revenue growth rate | 6.0% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 17 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,452 | 118 | 142 | 297 | 11 |
12/31/2024 | 1,360 | 85 | 114 | 255 | 15 |
12/31/2023 | 1,280 | 61 | 106 | 244 | 15 |
12/31/2022 | 1,202 | 40 | 30 | 169 | N/A |
9/30/2022 | 1,199 | -20 | 27 | 160 | N/A |
6/30/2022 | 1,174 | -40 | 44 | 171 | N/A |
3/31/2022 | 1,159 | -37 | 38 | 157 | N/A |
12/31/2021 | 1,139 | -64 | 70 | 182 | N/A |
9/30/2021 | 1,129 | -26 | 103 | 217 | N/A |
6/30/2021 | 1,153 | 2 | 122 | 232 | N/A |
3/31/2021 | 1,062 | -50 | 107 | 212 | N/A |
12/31/2020 | 1,051 | -37 | 76 | 186 | N/A |
9/30/2020 | 1,069 | -9 | 78 | 188 | N/A |
6/30/2020 | 1,065 | -4 | 62 | 175 | N/A |
3/31/2020 | 1,153 | 61 | 96 | 216 | N/A |
12/31/2019 | 1,168 | 65 | 105 | 235 | N/A |
9/30/2019 | 1,146 | 48 | 104 | 229 | N/A |
6/30/2019 | 1,127 | 52 | 115 | 235 | N/A |
3/31/2019 | 1,116 | 49 | 89 | 207 | N/A |
12/31/2018 | 1,102 | 12 | 110 | 219 | N/A |
9/30/2018 | 1,085 | 24 | 109 | 209 | N/A |
6/30/2018 | 1,060 | 41 | 84 | 187 | N/A |
3/31/2018 | 1,038 | 42 | 77 | 185 | N/A |
12/31/2017 | 1,027 | 82 | 64 | 177 | N/A |
9/30/2017 | 1,027 | 64 | 65 | 179 | N/A |
6/30/2017 | 1,019 | 35 | 17 | 123 | N/A |
3/31/2017 | 996 | 53 | 16 | 127 | N/A |
12/31/2016 | 962 | 37 | 64 | 158 | N/A |
9/30/2016 | 906 | 42 | N/A | 137 | N/A |
6/30/2016 | 867 | 51 | N/A | 154 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NUVA *'s forecast earnings growth (29.9% per year) is above the savings rate (7.5%).
Earnings vs Market: NUVA *'s earnings (29.9% per year) are forecast to grow faster than the MX market (9.2% per year).
High Growth Earnings: NUVA *'s earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NUVA *'s revenue (6% per year) is forecast to grow slower than the MX market (6.2% per year).
High Growth Revenue: NUVA *'s revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NUVA *'s Return on Equity is forecast to be high in 3 years time